How does 6 months of active bike commuting or leisure-time exercise affect insulin sensitivity, cardiorespiratory fitness and intra-abdominal fat? A randomised controlled trial in individuals with overweight and obesity by Blond, Martin Bæk et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: May 03, 2019
How does 6 months of active bike commuting or leisure-time exercise affect insulin
sensitivity, cardiorespiratory fitness and intra-abdominal fat? A randomised controlled
trial in individuals with overweight and obesity
Blond, Martin Bæk; Rosenkilde, Mads; Gram, Anne Sofie; Tindborg, Marie; Christensen, Anders Nymark;
Quist, Jonas Salling; Stallknecht, Bente Merete
Published in:
British Journal of Sports Medicine
Link to article, DOI:
10.1136/bjsports-2018-100036
Publication date:
2019
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Blond, M. B., Rosenkilde, M., Gram, A. S., Tindborg, M., Christensen, A. N., Quist, J. S., & Stallknecht, B. M.
(2019). How does 6 months of active bike commuting or leisure-time exercise affect insulin sensitivity,
cardiorespiratory fitness and intra-abdominal fat? A randomised controlled trial in individuals with overweight and
obesity. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2018-100036
   1Blond MB, et al. Br J Sports Med 2019;0:1–11. doi:10.1136/bjsports-2018-100036
How does 6 months of active bike commuting or 
leisure-time exercise affect insulin sensitivity, 
cardiorespiratory fitness and intra-abdominal fat? A 
randomised controlled trial in individuals with 
overweight and obesity
Martin Bæk Blond,  1 Mads Rosenkilde,1 Anne Sofie Gram,1 Marie Tindborg,1 
Anders Nymark Christensen,2 Jonas Salling Quist,1 Bente Merete Stallknecht1 
Original article
To cite: Blond MB, 
Rosenkilde M, Gram AS, et al. 
Br J Sports Med Epub ahead 
of print: [please include Day 
Month Year]. doi:10.1136/
bjsports-2018-100036
 ► Additional material is 
published online only. To view 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bjsports- 2018- 100036).
1Department of Biomedical 
Sciences, University Of 
Copenhagen, København N, 
Denmark
2Department of Applied 
Mathematics and Computer 
Science, Technical University 
of Denmark, Kongens Lyngby, 
Denmark
Correspondence to
Dr Martin Bæk Blond, 
Department of Biomedical 
Sciences, University Of 
Copenhagen, København, 1165, 
Denmark;  martinbp@ sund. ku. dk
MBB and MR contributed 
equally.
Accepted 13 February 2019
© Author(s) (or their 
employer(s)) 2019. No 
commercial re-use. See rights 
and permissions. Published 
by BMJ.
AbsTrACT
Objectives To evaluate effects of active bike 
commuting or leisure-time exercise of two intensities 
on peripheral insulin sensitivity (primary outcome), 
cardiorespiratory fitness and intra-abdominal adipose 
tissue mass (secondary outcomes).
Methods 188 physically inactive, healthy women and 
men (20-45 years) with overweight or class 1 obesity 
were recruited. In the 6-month trial, 130 participants 
were randomised to either: no intervention (CON), active 
commuting (BIKE) or leisure-time exercise of moderate 
(MOD, 50% VO2peak) or vigorous (VIG, 70% VO2peak) 
intensity. 100 completed follow-up testing. Exercise 
prescription was 5 days/week with a weekly exercise 
energy expenditure of 1600 kcal for women and 2100 kcal 
for men. Testing was performed at baseline, 3 months and 
6 months.
results Peripheral insulin sensitivity (ml/min/pmol 
insulin/L) increased (improved) by 24% (95% CI 6% to 
46%, p=0.01) in VIG compared with CON at 3 months. 
Peripheral insulin sensitivity increased (improved) by 
20% in BIKE (95% CI 1% to 43%, p=0.04) and 26% in 
VIG (95% CI 7% to 47%, p<0.01) compared with CON 
at 6 months. Cardiorespiratory fitness increased in all 
exercise groups compared with CON at 6 months; but 
the increase was higher in those that undertook vigorous 
exercise than those who did moderate exercise. Intra-
abdominal adipose tissue mass diminished across all 
exercise groups in comparison to CON at 6 months.
Conclusions Active bike commuting improved 
cardiometabolic health; as did leisure-time exercise. 
Leisure-time exercise of vigorous intensity conferred 
more rapid effects on peripheral insulin sensitivity as well 
as additional effects on cardiorespiratory fitness than did 
moderate intensity exercise.
Trial registration NCT01962259
InTrOduCTIOn
Physical inactivity and adiposity have reached 
pandemic proportions and pose major public health 
concerns, predisposing to cardiovascular diseases, 
type 2 diabetes and excess mortality.1–3 Insulin resis-
tance is a central aetiological factor linking lifestyle 
to many cardiometabolic disorders,4 with addi-
tional risk associated with low cardiorespiratory 
fitness5 and increased abdominal obesity.6 Exercise 
is a remedy for insulin resistance, low fitness and 
abdominal obesity7–9 and plays an important role in 
the prevention of type 2 diabetes10 and cardiovas-
cular disease.11 
Lack of time has been reported as a major barrier 
for the engagement in leisure-time exercise.12 13 
However, physical activity can take place in other 
domains of everyday life14 and active commuting 
represents an alternative means for increasing phys-
ical activity.15 16 In the recently published global 
action plan on physical activity for 2018–2030, 
WHO recommends to strive for increasing active 
transport,17 and policy makers are investing to 
improve bike infrastructure.18 19 Still, the current 
evidence to support beneficial health effects of 
active commuting by bike is based mainly on 
observational studies and only a few intervention 
studies.20 Population-based studies have found 
active commuting to be associated with lower total 
and abdominal adiposity, cardiovascular risk and 
mortality.21–25 Likewise, the few randomised26 27 and 
non-randomised28–30 intervention studies support 
beneficial effects of active commuting by bike on 
cardiorespiratory fitness and cardiovascular risk 
factors. To date no randomised controlled trials 
have addressed the effect of active commuting on 
insulin sensitivity or investigated whether active 
commuting improves cardiometabolic health simi-
larly to leisure-time exercise.20
Increasing exercise intensity represents another 
strategy, which can be used to address the lack of 
time for exercise by reducing the time required 
to combust a given amount of energy. Moreover, 
increasing exercise intensity17 31 32 rather than 
dose19 33 34 seems to induce additional cardiometa-
bolic health benefits in individuals with overweight 
and obesity. Still, the impact of exercise intensity on 
peripheral insulin sensitivity is uncertain.8
We designed the study ‘Governing Obesity - 
Active Commuting To Improve health and Well-
being in Everyday life (GO-ACTIWE)’ to evaluate 
the effects of active commuting by bike compared 
with leisure-time exercise of moderate and vigorous 
intensity on peripheral insulin sensitivity as the 
primary outcome measure and cardiorespiratory 
fitness and intra-abdominal adipose tissue mass 
as key secondary outcomes in physically inactive 
women and men with overweight and class I obesity.
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MeThOds
study design
We performed a 6-month single-centre, parallel-group, 
randomised controlled trial at the Department of Biomed-
ical Sciences, University of Copenhagen, from November 
2013 to June 2016 (scheduled date of closure). A comprehen-
sive description of the interdisciplinary study design has been 
published35 along with data on fat loss,36 low-grade inflamma-
tion,37 blood lipids and fibrin turnover.38 We initially planned 
a 12-month intervention, but on 2 February 2014 the interven-
tion was reduced to 6 months due to recruitment issues and an 
unexpectedly large withdrawal of eligible individuals during the 
run-in period. The study adhered to the declaration of Helsinki 
and written informed consent was obtained from all participants 
before inclusion.
We recruited healthy Caucasian (self-assigned) physically 
inactive individuals with overweight and class I obesity (BMI 
25–35 kg/m2) aged 20–45 years. Screening included a medical 
history and the following exclusion criteria were used; body 
fat <32% for women and <25% for men, peak oxygen uptake 
(VO2peak) >40 mL O2/kg/min for women and >45 mL O2/
kg/min for men, fasting plasma glucose >6.1 mmol/L, blood 
pressure >140/90 mm Hg, abnormal resting or working ECG, 
parents or siblings diagnosed with type 2 diabetes, habitual 
medication use (oral contraceptives excluded), and for women, 
current or planned pregnancy within the time frame of the inter-
vention. Potential participants went through a semistructured 
interview regarding physical activity habits and were excluded if 
engaging in structured exercise more than two times/week and/
or exceeding 25 km/week of active commuting. The exclusion 
criteria were chosen to recruit individuals that were physically 
active less than 1–2 hours per week.
randomisation and blinding
Participants were randomised by a lottery to one of the following 
four groups: control (CON), active commuting by bike (BIKE), 
or moderate (MOD) or vigorous (VIG) intensity leisure-time 
exercise, in a 1:2:2:2 ratio. The randomisation was stratified 
by gender and performed in blocks of 7 or 14 participants 
per strata. Cohabiting couples were offered to be randomised 
together. The researchers (JSQ, ASG, MBB) accompanying the 
participants during the lottery were blinded to the ratio of lots in 
the lottery. The researcher (MRL) who generated the blocks did 
not partake in the lottery. Neither participants nor researchers 
were blinded to group allocation after randomisation.
Interventions
The same target exercise energy expenditure was prescribed 
across all three exercise groups, with women aiming to expend 
1600 kcal/week and men 2100 kcal/week. Exercise was prescribed 
5 days/week with a prescribed exercise energy expenditure of 
320 kcal/day for women and 420 kcal/day for men, equilibrating 
exercise-induced energy expenditure across genders to ~33 kcal/
kg fat-free mass/week.36 The exercise frequency was ramped up 
during a 3-week period, starting with two exercise days in the 
first week and incrementing with one exercise day per week until 
reaching the final frequency of five exercise days per week.
In BIKE, participants were instructed to commute by bike 
to and from work/school and were, if needed, provided with a 
bicycle (Nishiki touring master, Nishiki, Denmark) for the dura-
tion of the intervention. An average target daily distance was 
calculated for participants in BIKE based on their energy expen-
diture while biking; this distance was regularly updated during 
the trial to ensure that the achieved energy expenditure corre-
sponded to that prescribed. To achieve the prescribed energy 
expenditure some participants in BIKE were asked to take a 
detour on the way to/from work or to use passive transportation 
for part of their commute. The exercise prescription in MOD 
and VIG only differed by the prescribed target exercise inten-
sity. Both groups had free access to a chain of fitness centres 
and participants were instructed to perform aerobic exercise (eg, 
walking, running, rowing, cross trainer or stationary cycling) at a 
heart rate corresponding to 50% or 70% of VO2peak-reserve,
39 
respectively.
The target exercise heart rate in MOD and VIG was calculated 
at baseline based on the heart rate—VO2 relationship obtained 
during the graded exercise tests used to assess cardiorespiratory 
fitness and was updated after 1½ and 3 months. Exercise heart 
rate (all exercise groups) and distance (BIKE) were monitored 
using Polar RC3 GPS (Polar, Finland). All training data (heart 
rate, duration and frequency) were uploaded online ( www. 
polarpersonaltrainer. com) to verify adherence, and participants 
and investigators were in weekly contact. In case of deviations, 
participants were asked to increase/decrease daily exercise 
energy expenditure by 25% until they were within this range 
again. Participants not achieving a total exercise energy expen-
diture of 80%–120% of prescription were defined as protocol 
deviators. Participants in CON were asked to maintain their 
sedentary lifestyle throughout the study period. Monetary incen-
tives (Danish Kr1000~£120) was provided on completion of an 
individual intervention segment defined as testing at baseline, 
3 months or 6 months, or the intervention itself. If participants 
did not wish to continue the prescribed intervention they were 
encouraged to partake in the follow-up testing, especially with 
regard to the measurement of the primary outcome at 6 months.
Measurements
All outcomes were obtained at baseline and after 3 months and 
6 months. Participants were advised to continue habitual eating 
throughout the study. Each test period comprised three separate 
test days. Test days 1 and 3 started in the morning (8:00 or 9:00) 
after an overnight fast (from 22:00 the night before) and test 
day 2 in the afternoon (15:00 to 18:00) after a 6-hour fast. At 
all occasions, participants transported themselves by means of 
car or public transport (bus or train) to the research facilities 
and avoided excess physical activity. At 3 months and 6 months, 
we informed participants in the exercise groups to schedule the 
last exercise bout 36–48 hours before testing to minimise acute 
effects in order to capture repetitive effects of regular exercise.40
Test day 1
Body weight and height were measured (Seca 767, Vogel & 
Halke, Hamburg, Germany) in light clothing and body compo-
sition was determined using dual-energy X-ray absorptiometry 
(DPX-IQ X-ray bone densitometer 4.7e, Lunar Corporation, 
Madison, Wisconsin, USA). Brachial blood pressure was recorded 
thrice after 10 min of rest and an average calculated. Waist 
circumference was measured at the narrowest point identified 
between the lowest rib and the iliac crest and an average three 
measurements calculated. Two sets of arterialised fasting blood 
samples were drawn to assess fasting plasma glucose and insulin. 
After this, peripheral insulin sensitivity was determined by a 
2-hour one-step hyperinsulinaemic-euglycaemic clamp41 using 
previously described procedures.33 Briefly, hyperinsulinaemia 
was obtained by a primed continuous infusion of 40 mU/m2/min 
exogenous human insulin (Actrapid, 100 IU/ml, Novo Nordisk, 
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Denmark). Plasma glucose was measured frequently and isogly-
caemia was maintained by a variable infusion of isotonic glucose. 
Arterialised blood samples were obtained at 30 min, 60 min, 90 
min and 120 min to determine concentrations of glucose and 
insulin. Peripheral insulin sensitivity was defined as the meta-
bolic clearance rate of glucose from 90 min to 120 min corrected 
for variations in the glucose concentration in the extracellular 
distribution space42 and divided by steady state plasma insulin 
concentration. Fasting insulin sensitivity was determined by the 
approximation formula for the homoeostasis model assessment 
of insulin resistance score (HOMA-IR).43
Test day 2
Cardiorespiratory fitness was determined using an electroni-
cally braked cycle (Lode Excalibur, Groeningen, Netherlands) 
and open circuit indirect respiratory calorimetry (Oxycon Pro, 
Jaeger, Würzburg, Germany). Following a 9-minute warm-
up, the workload was increased in a stepwise manner by 20 
watts/min and 25 watts/min for women and men, respectively. 
Attainment of VO2peak was accepted when a levelling off in 
oxygen consumption was observed despite increasing work-
load or as subjective exhaustion combined with a respiratory 
exchange ratio >1.15. Following the exercise test, participants 
had an intramuscular injection of 20 mg of hyoscinbutylbromid 
(Buscopan, Sanofi, Denmark) and images of the entire abdomen 
were obtained by MRI (3 Tesla BiographmMR, Siemens, 
Germany) using a T1-weighted sequence with water suppression 
(echo time 9.5 ms, repetition time 685 ms, slice thickness 6 mm, 
slice spacing 7.2 mm). Participants wore light clothing, lay supine 
in the scanner and performed breath-holds during image acqui-
sition. Intra-abdominal (visceral and retroperitoneal) adipose 
tissue volume in the region from the centre of intervertebral disc 
T10-T11 to the centre of disc L4-L5 was assessed using an auto-
mated segmentation procedure44 and the volume was converted 
to mass using an adipose tissue density of 0.92 g/mL.45
Test day 3
A mixed meal test was performed in order to access the effects 
of the interventions on the glucose metabolism under physio-
logical conditions that are closer to that of everyday life. The 
meal consisted of bread, cheese, jam and a juice with 460 kcal 
for women and 600 kcal for men with a macronutrient compo-
sition of 64 E% carbohydrate, 23 E% fat and 13 E% protein. 
Blood was sampled for determination of glucose and insulin 
levels before the meal and every 30 min for 3 hours postpran-
dially. The response to the meal was summarised calculating the 
area under the curve (AUC) for glucose and insulin using the 
trapezoid method.
All blood samples were analysed in one batch after completion 
of the trial by blinded investigators, using absorption photom-
etry (Roche Cobas 8000 c702 module) for glucose and elec-
trochemiluminescence immunoassay (Roche Cobas 8000 e602 
module) for insulin.
sample size
The trial was powered to detect changes in peripheral insulin 
sensitivity (primary outcome), intra-abdominal adipose tissue 
(secondary outcome) and cardiorespiratory fitness (secondary 
outcome) following 3 months and 6 months of intervention. 
All power calculations were based on two-sample t-tests, 
thereby ignoring the correlation in repeated measurements 
and were consequently, rather conservative. The α level was 
0.05 for all calculations. As the clinically relevant effect size for 
peripheral insulin sensitivity measured by the one-step hyper-
insulinaemic-euglycaemic clamp is not known, we powered the 
study based on the efficacy of previous exercise interventions 
performed by others and ourselves.33 46 47 In order to detect a 
20±24% (mean±SD) difference in peripheral insulin sensitivity 
between the exercise groups and CON with a power of 0.85, we 
would need at least 60 participants (40 in each exercise group 
and 20 in CON). In order attain a power of 0.80 for detecting 
a 16±24% difference between two exercise groups, we would 
need to include 74 participants (37 in each exercise group). 
Similar calculations for cardiorespiratory fitness and intra-ab-
dominal adipose tissue showed that a smaller number of partic-
ipants was needed.35 With an expected dropout rate of 20% we 
planned to include 175 participants, but due to a greater than 
expected rate of withdrawal before and during baseline testing, 
this was increased to 188 participants.35
statistical analysis
The statistical analysis of the repeated measures was based on 
the intention-to-treat principle and included all available data 
for all randomised participants. For the primary outcome a 
supplementary analysis including only per protocol completers 
was performed. All missing data were assumed to be missing at 
random, or completely at random, in relation to the outcomes. 
Analyses of repeated measures were performed using baseline 
constrained mixed linear models with the means as a func-
tion of time and group-by-time interaction, thereby ascribing 
all differences at baseline to the individual level. Gender was 
included in the model for the analysis of peripheral insulin 
sensitivity, cardiorespiratory fitness, clamp insulin levels and 
glucose disposal rate, plus all anthropometric measures, as these 
outcomes were expected to show a bimodal distribution due to 
known gender differences. The study was an efficacy study and 
the intervention effects were estimated by restricted maximum 
likelihood inference with comparisons of response profiles 
between groups. An unstructured covariance was used to model 
the association between the three repeated measurements and 
denominator degrees of freedom were computed by the method 
of Kenward and Rogers.48 The intervention effects were calcu-
lated as response profiles representing the difference between 
the individual groups at the given follow-up visit with adjust-
ment for covariates and for potential differences at baseline.
Analyses were assessed for adequacy of the assumptions of 
normality and homogeneity of variances with graphical methods, 
for the mixed linear models scaled residuals were inspected. 
Non-Gaussian distributed data (peripheral insulin sensitivity, 
fasting insulin, HOMA-IR, clamp insulin levels, glucose disposal 
rate and insulin AUC during the mixed meal) were logarithmi-
cally transformed to fit the distributional assumptions of the 
statistical analyses.
Descriptive data are presented as mean and SD for data with 
a Gaussian distribution and as median plus the 25th and 75th 
percentiles IQR for non-Gaussian distributed data. The results 
from the mixed linear models were expressed as estimated mean 
differences with 95% CIs for group comparisons and means aver-
aged over covariates (lsmeans) with 95% CIs for levels at a given 
time point. Comparison of exercise compliance between the 
three exercise groups was performed using analysis of variance 
(ANOVA) with post hoc t-tests to compare the individual groups 
in the case of a significant F-test and likewise non-Gaussian 
distributed data were analysed using one-way ANOVA on 
ranks (Kruskal-Wallis H test) and Wilcoxon two-sample test. 
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Completers and non-completers were compared at baseline by 
ANOVA with correction for gender for relevant outcomes.
A value of p≤0.05 was considered statistically significant. All 
statistical analyses were performed in SAS V.9.4 (SAS Institute).
Patient involvement
There were no patients involved in defining the research ques-
tions or the outcome measured, nor were any patients involved 
in developing the design of the study. We did not seek patient 
advice on interpretation or writing of the results.
resulTs
Participants
The participant flow is presented in figure 1. We included 188 
individuals and randomised 130 (women=69; men=61) to 
CON (n=18), BIKE (n=35), MOD (n=39) and VIG (n=38). 
One participant (BIKE) was referred for surgery and excluded 
from further analysis after the discovery of an intra-abdominal 
tumour. Baseline participant characteristics are presented in 
table 1.
Seventy-seven per cent of the participants completed the 
study; 67% completed the study per protocol. An additional 
10% completed measurements of the primary outcome at 
6 months, but expended less than 80% of the prescribed total 
exercise energy expenditure (protocol deviators). Thus, 23% of 
the participants were missing at 6 months. Six participants (BIKE 
3, MOD 2 and VIG 1) attended test days at 3 months but not at 
6 months and conversely 12 participants (BIKE 3, MOD 3  and 
VIG 6) attended the testing at 6 months but not at 3 months. The 
loss to follow-up at 6 months was 11% for CON, 43% for BIKE, 
15% for MOD and 18% for VIG. Non-completers did not differ 
from completers with respect to peripheral insulin sensitivity 
(14%, 95% CI –12% to 34%, p=0.23), cardiorespiratory fitness 
(−0.2 mL O2/kg/min, 95% CI –1.9 to 1.6, p=0.86), or intra-ab-
dominal adipose tissue (−111 g, 95% CI –450 to 240, p=0.51) 
(online supplementary table 1).
Figure 1 Participant flow chart. BIKE, active commuting group; CON, control group; MOD, moderate intensity exercise group; VIG, vigorous intensity 
exercise group.
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Two participants in BIKE and one in VIG suffered from inju-
ries related to the intervention; all three completed the interven-
tion following a recuperation period, two of them with reduced 
energy expenditure compared with the prescribed.
exercise compliance
The compliance with the exercise prescription for participants 
who attended measurements of the primary outcome at 3 
months and 6 months and thereby provided follow-up data for 
the analyses is presented in table 2. The duration of the exercise 
intervention, the exercise frequency and the compliance with the 
number of prescribed exercise days was similar across the three 
intervention groups. As per study design, the exercise intensity 
was vigorous in VIG and moderate in MOD. BIKE exercised 
at moderate intensity. The compliance with the prescribed total 
exercise energy expenditure was high in all exercise groups 
(median 85–101%), but was lower in VIG compared with MOD, 
in particular, for the 0–6 months period. This was in part due 
to the fact that we managed to retain more participants in VIG, 
who did little or no exercise.
Primary outcome analysis
Peripheral insulin sensitivity was improved by 24% in VIG 
compared with CON at 3 months, whereas BIKE and MOD 
did not differ from CON (table 3 and figure 2A). At 3 months, 
peripheral insulin sensitivity in VIG was increased compared 
with BIKE, but the increase was below the predefined relevant 
effect size and did not reach statistical significance (15%, 95% CI 
–0.01 to 33, p=0.06). At 6 months, peripheral insulin sensi-
tivity was increased in VIG (26%) and BIKE (20%) compared 
with CON, whereas the increase in MOD (17%) was below the 
prespecified target effect size of 20% and did not reach statistical 
Table 1 Baseline participant characteristics
All participants (n=129) COn (n=18) bIKe (n=34) MOd (n=39) VIG (n=38)
Age, years* 34 (7) 35 (7) 35 (7) 32 (7) 36 (7)
Female, number (%)† 69 (53%) 9 (50%) 19 (54%) 21 (54%) 20 (53%)
Educational level
  Less than college† 67 (52%) 7 (39%) 23 (66%) 21 (53%) 16 (42%)
  College† 42 (32%) 5 (28%) 7 (20%) 12 (31%) 18 (48%)
  Graduate school† 21 (16%) 6 (33%) 5 (14%) 6 (16%) 4 (10%)
Job status
  Employed, No (%)† 102 (78%) 16 (89%) 28 (80%) 27 (69%) 31 (82%)
  Unemployed, No (%)† 11 (8%) 0 (0%) 2 (5%) 5 (13%) 4 (11%)
  Student, No (%)† 17 (13%) 2 (11%) 5 (15%) 7 (18%) 3 (7%)
Civil status
  Single, No (%)† 34 (26%) 3 (17%) 8 (23%) 13 (33%) 10 (26%)
  Cohabiting, No (%)† 96 (74%) 15 (83%) 27 (77%) 26 (67%) 28 (74%)
Anthropometrics
  Weight, kg* 89.9 (12.5) 91.7 (12.3) 89.6 (11.2) 88.6 (11.6) 90.8 (14.6)
  Body mass index, kg/m2* 29.7 (2.6) 30.1 (2.9) 29.6 (3.2) 29.1 (2.0) 29.8 (2.5)
  Fat-free mass, kg‡ 53.3 (44.4; 64.9) 52.5 (44.3; 64.1) 54.7 (45.2; 59.7) 52.0 (44.0; 64.9) 51.3 (43.9; 69.0)
  Fat mass, kg* 34.7 (7.2) 36.1 (6.3) 34.4 (8.4) 34.3 (7.3) 34.8 (6.4)
  Waist circumference, cm* 94 (10) 96 (9) 95 (10) 92 (10) 94 (11)
  Intra-abdominal adipose tissue, g‡ 1722 (1154; 2703) 2019 (1403; 2514) 1824 (1244; 2629) 1499 (1006; 2253) 1716 (1112; 2866)
Blood pressure
  Systolic, mm Hg* 119 (12) 118 (12) 118 (12) 118 (11) 120 (14)
  Diastolic, mm Hg* 76 (9) 77 (11) 77 (11) 75 (7) 77 (8)
Cardiorespiratory fitness
  mL/min* 2628 (601) 2710 (709) 2620 (510) 2590 (580) 2637 (644)
  mL/min/kg* 29.0 (5.1) 29.3 (5.9) 29.2 (4.5) 28.8 (5.2) 29.8 (2.4)
  Maximal power, watt* 190 (46) 198 (53) 189 (40) 189 (46) 189 (48)
Glucose metabolism
  Fasting glucose, mmol/L* 5.3 (0.4) 5.3 (0.4) 5.3 (0.4) 5.2 (0.4) 5.3 (0.4)
  Fasting insulin, pmol/L‡ 68.0 (53.4; 94.5) 64.5 (47.6; 115.2) 78.2 (48.6; 110.2) 69.3 (53.6; 96.5) 62.3 (53.5; 75.6)
  HOMA-IR‡ 2.26 (1.79; 3.09) 2.09 (1.53; 3.96) 2.64 (1.63; 3.69) 2.27 (1.83; 3.08) 2.12 (1.84; 2.65)
  Peripheral insulin sensitivity, ml/min/
pmolinsulin/L‡
0.66 (0.51; 0.91) 0.69 (0.52; 0.80) 0.63 (0.45; 0.99) 0.66 (0.56; 0.88) 0.70 (0.53; 0.88)
  Clamp glucose disposal rate, mg/min‡ 309 (242; 448) 303 (240; 389) 298 (240; 424) 357 (235; 448) 305 (264; 473)
  Clamp glucose levels, mmol/L* 5.4 (0.5) 5.3 (0.4) 5.4 (0.5) 5.5 (0.6) 5.5 (0.5)
  Clamp insulin levels, pmol/L* 520 (108) 503 (139) 512 (115) 535 (110) 518 (82)
  AUC glucose mixed meal challenge* 1074 (126) 1116 (142) 1068 (122) 1080 (130) 1055 (120)
  AUC insulin mixed meal challenge, 103‡ 51.3 (37.8; 71.4) 51.3 (42.8; 68.4) 48.5 (34.4; 74.2) 51.4 (37.9; 65.6) 53.1 (34.6; 63.8)
Data are presented as *mean (SD), †number with the percentage of n, or as ‡median (25th centile; 75th centile). Peripheral insulin sensitivity: metabolic clearance rate of 
glucose measured by the hyperinsulinaemic-euglycaemic clamp.
AUC, area under the curve; BIKE, active commuting group; CON, control group; HOMA-IR, homoeostasis assessment of insulin resistance; MOD, moderate intensity exercise 
group; VIG, vigorous intensity exercise group.
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significance (p=0.053). Summary of the raw data used for anal-
ysis and the number of participants examined at each time point 
can be found in online supplementary table S2.
The supplementary per protocol analysis for peripheral 
insulin sensitivity included 88 participants (women=43; 
men=45) (CON=14; BIKE=19; MOD=31; VIG=24). At 
3 months, the peripheral insulin sensitivity in both MOD (19%, 
95% CI 1% to 40%, p=0.03) and VIG (28%, 95% CI 9% to 
52%, p<0.01) was increased compared with CON, and the 
peripheral insulin sensitivity of VIG was higher than in BIKE 
(18%, 95% CI 1% to 37%, p=0.04). At 6 months, peripheral 
insulin sensitivities in BIKE (27%, 95% CI 6% to 51%), MOD 
(25%, 95% CI 6% to 47%) and VIG (35%, 95% CI 14% to 
51%) were all higher than in CON (p<0.01 for all) with no 
differences between the three exercise groups (p>0.26).
secondary outcome analysis
At 3 months, cardiorespiratory fitness was higher in all exer-
cise groups compared with CON and this effect remained at 6 
months (figure 2B, table 3 and online supplementary table S2). 
Interestingly, cardiorespiratory fitness was higher in BIKE and 
VIG compared with MOD at 3 months. At 6 months, cardiore-
spiratory fitness was higher in VIG compared with MOD.
All exercise groups had a lower intra-abdominal adipose 
tissue mass compared with CON at 3 months and at 6 months; 
at 6 months the effect in all exercise groups surpassed the 
predefined least relevant difference (−215 g) (figure 2C, table 3 
and online supplementary table S2). The largest difference 
observed between the exercise groups was −117 g (95% CI –256 
to 23, p=0.1) for MOD compared with VIG at 6 months.
body composition and other metabolic outcomes
Changes in body composition are shown in table 4. All exer-
cise groups exhibited reductions in body weight and fat mass 
compared with CON. Fat mass was lower in VIG compared with 
MOD at 6 months. Waist circumference was reduced in both 
MOD and VIG compared with CON, whereas the reduction in 
BIKE did not reach statistical significance.
The exercise groups did not differ from CON with regards 
to fasting plasma glucose or insulin at 3 months, but fasting 
plasma insulin was decreased in VIG compared with CON after 
6 months. Consequently, HOMA-IR was lower in VIG compared 
with CON (table 4). Fasting plasma insulin and HOMA-IR were 
also lower in VIG compared with BIKE and MOD at 6 months. 
Postprandial glycaemic control as determined by total AUC for 
glucose following a mixed meal challenge was not changed in 
any of the intervention groups compared with CON (table 4). 
However, AUC for insulin was decreased in VIG compared with 
CON at 3 months and 6 months (table 4).
Table 2 Exercise compliance for participants in BIKE, MOD and VIG attending measurement of the primary outcome at 3 months and/or 6 months
0–3 months bIKe (n=20) MOd (n=32) VIG (n=26)
Exercise intervention duration, days 93 (86; 107) 97 (85; 106) 92 (89; 102)
Exercise frequency, exercise days/week 4.7 (4.3; 5.1) 5.0 (4.7; 5.3) 5.1 (4.6; 5.3)
Compliance, % of prescribed days 95 (84; 103) 100 (93; 105) 102 (91; 105)
Exercise duration, min/exercise day 46 (39; 54) 52 (46; 61)* 34 (32; 38)*† 
Exercise energy expenditure, kcal/exercise day
  Women 331 (268; 348) 342 (303; 377) 300 (271; 334)
  Men 448 (427; 493) 455 (395; 515) 410 (307; 474)
Total energy expenditure, % prescribed kcal 101 (88; 110) 100 (92; 118) 97 (77; 104)§
Participants combusting <25% of prescribed kcal
  0–3 months, n 0 0 0
Exercise intensity, %VO2peak reserve 55 (47; 60) 51 (49; 53) 68 (61; 74)‡† 
Exercise intensity, MET 4.9 (4.6; 5.9) 4.9 (4.3; 5.4) 6.4 (5.5; 7.2)‡† 
Heart rate reserve, % 59 (52; 62) 53 (48; 54) 70 (67; 73)‡† 
0–6 months bIKe (n=20) MOd (n=33) VIG (n=31)
Exercise intervention duration, days 190 (181; 198) 188 (182; 196) 188 (183; 198)
Exercise frequency, exercise days/week 4.4 (4.0; 4.9) 4.7 (4.2; 4.9) 4.6 (3.5; 4.9)
Compliance, % of prescribed days 88 (80; 97) 94 (84; 99) 92 (69; 98)
Exercise duration, min/exercise day 42 (38; 53) 54 (48; 60)* 37 (33; 41)*† 
Exercise energy expenditure, kcal/exercise day
  Women 322 (315; 355) 322 (294; 371) 300 (275; 322)
  Men 473 (426; 501) 471 (384; 504) 428 (370; 499)
Total exercise energy expenditure, % prescribed kcal 94 (90; 99) 91 (86; 109) 85 (65; 97)(†)§
Participants combusting <25% of prescribed kcal
  0–3 months, n 0 1 2
  3–6 months, n 1 2 7
  0–6 months, n 0 0 6
Exercise intensity, %VO2peak reserve 55 (47; 59) 50 (47; 52) 67 (58; 71)‡† 
Exercise intensity, MET 5.3 (4.6; 6.4) 4.9 (4.3; 5.5) 6.1 (5.0; 7.1)*† 
Heart rate reserve, % 59 (53; 62) 52 (49; 56) 68 (64; 72)*† 
Data are presented as mean (SD) or median (25th centile; 75th centile). 
*P<0.05 compared with BIKE, †p<0.001 compared with BIKE, ‡p<0.001 compared with MOD; §p<0.05 compared with MOD, () indicate p=0.05–0.10.
%VO2peak-reserve, percentage of peak oxygen uptake-reserve; BIKE, active commuting group; MET, metabolic equivalent; MOD, moderate intensity exercise group; VIG, vigorous 
intensity exercise group.
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Six months of active commuting by bike led to improvements in 
peripheral insulin sensitivity and cardiorespiratory fitness on par T
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Figure 2 Peripheral insulin sensitivity, cardiorespiratory fitness and 
intraabdominal adipose tissue mass during the intervention. Effects 
of active commuting and leisure-time exercise on peripheral insulin 
sensitivity, cardiorespiratory fitness and intra-abdominal adipose tissue. 
Depicted values are means, and 95% CIs of the mean, estimated by the 
mixed linear models used in the analyses. All analyses were corrected 
for gender. *P<0.05 compared with CON, †p<0.05 compared with BIKE, 
‡p<0.05 compared with MOD, ()indicate p value 0.05–0.10. BIKE, active 
commuting group; CON, control group; MCR, metabolic clearance rate 
of glucose; MOD, moderate intensity exercise group; VIG, vigorous 
intensity exercise group; VO2peak, peak oxygen uptake.
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with those achieved by vigorous intensity leisure-time exercise. 
In addition, cardiorespiratory fitness increased in an intensity 
dependent manner in the leisure-time domain. Intra-abdominal 
adiposity decreased similarly across all exercise groups.
The GO-ACTIWE trial is the first randomised controlled trial 
to investigate whether long-term active commuting by bike and 
leisure-time exercise conveys similar cardiometabolic health 
benefits. Also, this is the first trial to assess the effect of active 
commuting by bike on peripheral insulin sensitivity. In addition, 
the GO-ACTIWE trial is of a substantial magnitude and dura-
tion compared with previous randomised controlled trials inves-
tigating cardiometabolic effects of active commuting by bike.26 27
limitations
Nevertheless, a number of limitations need to be addressed. 
First, for practical reasons the exercise energy expenditure and 
intensity were not measured directly during the exercise sessions, 
but estimated from the heart rate during the exercise via the 
linear relationship between heart rate and oxygen consumption 
derived from the exercise tests. In addition, the exercise test 
was performed on a stationary bicycle. There is a concern that 
this could bias the results for cardiorespiratory fitness by giving 
BIKE an advantage compared with the other exercise groups, 
though these groups were encouraged to use a stationary bike 
as part of their exercise. Furthermore, the study was performed 
in the greater Copenhagen area, which is highly conducive for 
commuting by bike. While this is ideal for an efficacy study, our 
findings cannot be readily generalised to other urban settings. 
Moreover, some participants in the BIKE group were asked to 
take a detour or to passively commute part of the way to ensure 
energy expenditure was in the required range and this detracts 
from the ecological validity of the study.
Another limitation of the study was the 23% loss to follow-up, 
which was particularly pronounced in the BIKE and VIG groups. 
While the retention rate in VIG is comparable to previous 
randomised trials of similar duration and exercise amount,31 32 
the level of retention in BIKE was disappointing. Indeed bike is 
the preferred mode of transportation to and from work/school 
in the Copenhagen area,49 and we speculate that the inclusion of 
non-habitual bike commuters could in part explain the higher 
than expected dropout in BIKE. Though we performed the 
statistical analysis according to an intention-to-treat principle, 
the missing data made it impossible to conduct a full intention-
to-treat analysis. However, the main analysis showed similar 
results as the per protocol analysis and we regard the results 
obtained as reliable.
exercise intensity and insulin sensitivity
The role of exercise intensity for insulin sensitivity is contro-
versial,8 potentially owing to differences in methodology and 
study populations. Larger effects have been suggested from 
moderate compared with vigorous intensity exercise50 and for 
high compared with low weekly exercise duration.51 Contrary 
to this, we found vigorous intensity exercise to convincingly 
increase peripheral insulin sensitivity, whereas the uncertainty of 
the effect in MOD did not allow us to confidently claim an effect 
of moderate intensity exercise on peripheral insulin sensitivity. 
The findings were obtained in spite of a lower total exercise 
energy expenditure in VIG compared with MOD. The GO-AC-
TIWE trial was powered to detect a 20% difference in peripheral 
insulin sensitivity and with the prior knowledge that exercise 
increases insulin sensitivity8 we believe that lack of statistical 
power was the reason for not finding a conclusive effect in 
MOD. Importantly, the difference between effects in VIG and 
MOD was not great enough to claim superiority of VIG.
Our results extend the conclusions of two small randomised 
controlled trials which reported that only endurance type 
exercise above moderate intensity improved peripheral insulin 
sensitivity in elderly participants.52 53 The peripheral tissues, 
the skeletal muscle in particular, are the prime targets for exer-
cise with regards to the glucose metabolism.54 Interestingly, 
the changes in the whole body measures of insulin sensitivity 
(HOMA-IR and AUC for insulin during the meal test) largely 
followed the same pattern as the changes in peripheral insulin 
sensitivity. However, only the VIG group experienced convincing 
effects, indicating that the  improvements in VIG were large 
enough to elicit effects on the wider glucose metabolism. Thus, 
our study adds support to the importance of exercise intensity 
for improving the glucose metabolism.
exercise and intra-abdominal obesity
Previous studies have shown exercise to be the most efficient 
lifestyle intervention for reduction of intra-abdominal adipose 
tissue,7 while the effect of exercise intensity on intra-abdominal 
adipose tissue is still unclear. Quantifying a large proportion of 
the intra-abdominal adipose tissue, we found a 15–20% decrease 
in all exercise groups at 6 months. These findings were largely 
mirrored by the changes in waist circumference.
exercise intensity and cardiorespiratory fitness
Adding another brick in the wall of the current literature,31 we 
found that improvements in cardiorespiratory fitness increased 
with exercise intensity. A novel finding is that improvements in 
cardiorespiratory fitness were similar after active commuting by 
bike and vigorous intensity leisure-time exercise. Low cardio-
respiratory fitness is associated with increased risk of type 
2 diabetes, cardiovascular disease and all-cause mortality, and 
a 10% increase in cardiorespiratory fitness is associated with a 
15–20% reduction in fatal cardiovascular disease and possibly an 
even greater decrease in all-cause mortality.5 We recruited partic-
ipants with low cardiorespiratory fitness and observed increases 
in cardiorespiratory fitness in excess of 10% in all exercise 
groups indicating clinical significance of all three interventions.
Healthcare professionals and policy makers can encourage 
active commuting by bike as an alternative or a supplement 
What are the findings?
 ► 6 months of active commuting by bike provided 
similar improvements in peripheral insulin sensitivity, 
cardiorespiratory fitness, and intra-abdominal adiposity as 
leisure-time exercise for women and men with overweight 
and obesity. 
 ► Vigorous intensity leisure-time exercise, but not moderate 
intensity exercise, improved peripheral insulin sensitivity by 
26%.
how might it impact on clinical practice in the future?
 ► Healthcare  professionals and policy makers can encourage 
active commuting by bike as an adjunct or alternative to 
leisure-time exercise for improving cardiometabolic health 
outcomes in physically inactive women and men with 
overweight and obesity.
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to leisure-time exercise to improve cardiometabolic health 
in physically inactive women and men with overweight and 
class II obesity. Future research should focus on how passive 
commuters can be turned into active commuters and how to 
consolidate this behaviour.
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